Pediatric Nephrology

, Volume 21, Issue 6, pp 842–845 | Cite as

Medication errors and patient complications with continuous renal replacement therapy

  • Jeffrey F. BarlettaEmail author
  • Gina-Marie Barletta
  • Patrick D. Brophy
  • Norma J. Maxvold
  • Richard M. Hackbarth
  • Timothy E. Bunchman
Original Article


Continuous renal replacement therapy (CRRT) is commonly used for renal support in the intensive care unit. While the risk of medication errors in the intensive care unit has been described, errors related specifically to CRRT are unknown. The purpose of this study is to characterize medication errors related to CRRT and compare medication errors that occur with manually compounded solutions versus commercially available solutions. We surveyed three separate internet-based, pediatric list serves that are commonly used for communications for programs utilizing CRRT. Data regarding CRRT practices and medication errors were recorded. Medication errors were graded for degree of severity and compared between programs using manually compounded dialysis solutions versus commercially available dialysis solutions. In a survey with 31 program responses, 18 reported medication errors. Two of the 18 were related to heparin compounding, while 16/18 were due to solution compounding errors. Half of the medication errors were classified as causing harm, two of which were fatal. All medication errors were reported by programs that manually compounded their dialysis solutions. Medication errors related to CRRT are associated with a high degree of severity, including death. Industry-based, commercially available solutions can decrease the occurrence of medication errors due to CRRT.


Medication errors Continuous Dialysis Dialysis solutions 


  1. 1.
    Bunchman TE, McBryde KD, Mottes TE, Gardner JJ, Maxvold NJ, Brophy PD (2001) Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 16:1067–1071CrossRefGoogle Scholar
  2. 2.
    Burchardi H (1998) History and development of continuous renal replacement techniques. Kidney Int 53 [Suppl 66]:S12–S124Google Scholar
  3. 3.
    Palevsky PM, Bunchman TE, Tetta C (2002) The Acute Dialysis Quality Initiative—Part V: operational characteristics of CRRT. Adv Ren Replace Ther 9:268–272CrossRefGoogle Scholar
  4. 4.
    Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR (1998) Diffusive vs convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 26:1995–2000CrossRefGoogle Scholar
  5. 5.
    Barenbrock M, Hausberg M, Matzkies F, de la Motte S, Schaefer RM (2000) Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58:1751–1757CrossRefGoogle Scholar
  6. 6.
    New Canadian guidelines released over potassium chloride-linked products and CRRT solutions after ESRD patient deaths (2004). Nephrology News & Issues 18, p 12Google Scholar
  7. 7.
    The National Coordination Council for Medication Error Reporting and Prevention (1996) New release: medication error council promotes categorization index. September 4.
  8. 8.
    Daschner M (2005) Drug dosage in children with reduced renal function. Pediatr Nephrol 20:1675–1686CrossRefGoogle Scholar
  9. 9.
    Vidal L, Shavit M, Fraser A, Paul M, Leibovici L (2005) Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 331:263CrossRefGoogle Scholar
  10. 10.
    van Rossum LK, Mathot RA, Cransberg K, Zietse R, Vulto AG (2005) Estimation of the glomerular filtration rate in children: which algorithm should be used? Pediatr Nephrol 20:1769–1775CrossRefGoogle Scholar
  11. 11.
    Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985CrossRefGoogle Scholar
  12. 12.
    Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS (2001) Medication administration errors in adult patients in the ICU. Intensive Care Med 27:1592–1598CrossRefGoogle Scholar
  13. 13.
    Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Budick E, Stone PH, Lilly CM, Katz JT, Czeisler CA, Bates DW (2005) The critical care safety study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 33:1694–1700CrossRefGoogle Scholar
  14. 14.
    Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration (CVVH): normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248–1252CrossRefGoogle Scholar
  15. 15.
    Tobe SW, Aujla P, Walele AA, Oliver MJ, Naimark DM, Perkins NJ, Beardsall M (2003) A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 18:121–129CrossRefGoogle Scholar
  16. 16.
    Mehta RL, McDonald BR, Aguilar MM, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976–981CrossRefGoogle Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  • Jeffrey F. Barletta
    • 1
    Email author
  • Gina-Marie Barletta
    • 2
  • Patrick D. Brophy
    • 3
  • Norma J. Maxvold
    • 4
  • Richard M. Hackbarth
    • 4
  • Timothy E. Bunchman
    • 2
  1. 1.Department of PharmacySpectrum HealthGrand RapidsUSA
  2. 2.Pediatric Nephrology & TransplantationDeVos Children’s HospitalGrand RapidsUSA
  3. 3.Pediatric NephrologyUniversity of MichiganAnn ArborUSA
  4. 4.Pediatric Critical CareDeVos Children’s HospitalGrand RapidsUSA

Personalised recommendations